Capital Research Global Investors
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1422848
Los Angeles, CA
Position in BMRN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$200,521,024
+$3,292,629 QoQ
Shares Held
3,504,387
+0.4% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#14
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $14,161,458,348 across 17 Biotechnology names. BMRN ranks #3 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,490,637 | $9,681,584,117 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,750,699 | $2,935,252,919 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
3,504,387 | $200,521,024 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
5,344,701 | $199,197,006 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,621,890 | $185,236,528 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,532,303 | $170,131,602 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
1,388,881 | $159,262,984 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,686,625 | $143,683,583 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,521,024 | 3,504,387 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $197,228,395 | 3,491,386 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $151,385,266 | 2,547,287 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $137,436,199 | 2,537,596 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,541,588 | 391,879 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $646,859,801 | 9,150,655 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $853,949,173 | 12,991,772 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $737,690,386 | 10,494,955 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $797,988,958 | 9,692,566 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $569,514,531 | 6,520,661 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,038,890,885 | 10,774,641 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $532,469,985 | 6,017,970 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $585,612,853 | 6,756,032 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $700,999,173 | 7,208,959 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $584,822,093 | 5,651,001 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $418,487,449 | 4,936,740 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $408,992,123 | 4,935,346 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $723,811,407 | 9,387,956 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $1,119,571,906 | 12,672,008 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,363,815,980 | 17,645,439 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,842,888,298 | 22,086,389 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,666,986,321 | 22,076,365 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,936,103,739 | 22,078,957 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,678,572,972 | 22,063,262 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,721,592,811 | 22,065,776 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,862,432,221 | 22,040,618 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||